CenturyLink Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

CenturyLink Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-622	Closed	-$107K	–	295
2015 Q1	$107K	Buy	+622	New	+$107K	0.04%	256
2014 Q4	–	Sell	-4,430	Closed	-$711K	–	261
2014 Q3	$711K	Buy	4,430 +1,288	+41%	+$198K	0.24%	155
2014 Q2	$462K	Buy	3,142 +1,441	+85%	+$200K	0.14%	181
2014 Q1	$236K	Buy	1,701 +692	+69%	+$104K	0.08%	215
2013 Q4	$128K	Sell	1,009 -104	-9%	-$10.8K	0.04%	224
2013 Q3	$102K	Buy	+1,113	New	+$89.8K	0.03%	243

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CenturyLink Investment Management's JAZZ Position: Q2 2015 in Review

CenturyLink Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2015, closing a stake of 622 shares — an estimated $107K sold.

CenturyLink Investment Management first reported a position in JAZZ in Q3 2013 and held it in 6 quarters. The position peaked at $711K in Q3 2014. 374 funds tracked by Wall St. Rank hold JAZZ as of Q2 2015.

CenturyLink Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
CenturyLink Investment Management sold 622 Jazz Pharmaceuticals shares in Q2 2015, an estimated $107K.
CenturyLink Investment Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 6 quarters.
CenturyLink Investment Management's Jazz Pharmaceuticals position peaked at $711K in Q3 2014.
374 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2015.

Based on CenturyLink Investment Management's 13F filing for Q2 2015, filed 10 Jul 2015.